MORPHABOND ER Drug Patent Profile

✉ Email this page to a colleague

When do Morphabond Er patents expire, and what generic alternatives are available?

Morphabond Er is a drug marketed by Ohemo Life and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-three patent family members in ten countries.

The generic ingredient in MORPHABOND ER is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Morphabond Er

A generic version of MORPHABOND ER was approved as morphine sulfate by HOSPIRA on September 30^th, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for MORPHABOND ER?
What are the global sales for MORPHABOND ER?
What is Average Wholesale Price for MORPHABOND ER?

Summary for MORPHABOND ER

International Patents:	23
US Patents:	2
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	11
Patent Applications:	3,492
Drug Prices:	Drug price information for MORPHABOND ER
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for MORPHABOND ER
DailyMed Link:	MORPHABOND ER at DailyMed

Drug patent expirations by year for MORPHABOND ER

Paragraph IV (Patent) Challenges for MORPHABOND ER

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
MORPHABOND ER	Extended-release Tablets	morphine sulfate	15 mg, 30 mg, 60 mg and 100 mg	206544	1	2019-01-28

US Patents and Regulatory Information for MORPHABOND ER

MORPHABOND ER is protected by two US patents.

Patents protecting MORPHABOND ER

Pharmaceutical compositions configured to deter dosage form splitting
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Abuse resistant drugs, method of use and method of making
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-001	Oct 2, 2015		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-004	Oct 2, 2015		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Ohemo Life	MORPHABOND ER	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	206544-002	Oct 2, 2015		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for MORPHABOND ER

See the table below for patents covering MORPHABOND ER around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	2923102	MEDICAMENTS RESISTANT AUX ABUS, PROCEDES D'UTILISATION ET DE FABRICATION (ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING)	⤷ Sign Up
China	101801350	Abuse resistant drugs, method of use and method of making	⤷ Sign Up
Japan	2016138126	乱用抵抗性医薬組成物、その使用方法および作製方法 (ABUSE RESISTANT PHARMACEUTICAL COMPOSITIONS, METHOD OF USING AND PRODUCING THEREOF)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for MORPHABOND ER

Paragraph IV (Patent) Challenges for MORPHABOND ER

Patents protecting MORPHABOND ER

Make Better Decisions: Try a trial or see plans & pricing